Novavax Announces Positive Results of COVID-19 Vaccine in Pedi...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Feb. 11, 2022 /PRNewswire-AsiaNet/ -- - PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population- Trial demonstrated 82% clinical efficacy against Delta variant- Immune responses we...
Authors: LATEST ASIANET NEWS RELEASES